Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
Completed · Phase 2
Conditions studied: Head and Neck Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and radiation therapy in treating patients with stage IV cancer of the head and neck.
Key facts
- Study ID
- NCT00002932
- Run by
- Radiation Therapy Oncology Group
- People needed
- 60
- Starts
- 1997-05-01
- Expected to finish
- 2005-03-01
- Last updated by the study team
- 2014-11-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Diego Cancer Center — La Jolla, California, United States
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- MBCCOP - LSU Medical Center — New Orleans, Louisiana, United States
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
- CCOP - Baptist Cancer Institute — Memphis, Tennessee, United States
- University of Tennessee, Memphis Cancer Center — Memphis, Tennessee, United States
- Vanderbilt Cancer Center — Nashville, Tennessee, United States
- Fletcher-Allen Health Care — Burlington, Vermont, United States
- Green Mountain Oncology Group — Rutland, Vermont, United States
- Naval Medical Center, Portsmouth — Portsmouth, Virginia, United States
- University Cancer Center — Seattle, Washington, United States
- University of Washington Neutron Facility and Cancer Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.